Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
EJNMMI Research|November 27, 2015
[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgeryMargret Schottelius, Martina Wirtz, Matthias Eiber, et al.
EJNMMI Research|August 24, 2018
Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicityMartina Wirtz, Alexander Schmidt, Margret Schottelius, et al.
Tomography (Ann Arbor, Mich.)|July 26, 2018
First <sup>18</sup>F-Labeled Pentixafor-Based Imaging Agent for PET Imaging of CXCR4 Expression In VivoAndreas Poschenrieder, Theresa Osl, Margret Schottelius, et al.
Chemical Communications (Cambridge, England)|February 14, 2017
Dendritic poly-chelator frameworks for multimeric bioconjugationDominik Reich, Alexander Wurzer, Martina Wirtz, et al.
ACS Omega|August 9, 2018
Effect of Carbohydration on the Theranostic Tracer PSMA I&TAlexander Schmidt, Martina Wirtz, Stefanie Felicitas Färber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2016
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and EfficacyRichard P Baum, Harshad R Kulkarni, Christiane Schuchardt, et al.
BJU International|November 19, 2016
Value of <sup>111</sup> In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-upIsabel Rauscher, Charlotte Düwel, Martina Wirtz, et al.
Clinical Nuclear Medicine|June 9, 2016
Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate CancerIsabel Rauscher, Tobias Maurer, Michael Souvatzoglou, et al.
Pageof 1